Search results (3)
« Back to NewsNew clinical study launched examining the role of insulin in breast cancer treatment response
28 January 2026
A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer
3 December 2025
Keaton Jones, Consultant Hepatobiliary and Pancreatic Surgeon at Oxford University Hospitals NHS Foundation Trust and Senior Clinical Researcher in the Department of Oncology at the University of Oxford, has received a Wellcome Trust Early Career Award to investigate the role of macrophage metabolism in determining therapeutic responses in pancreatic cancer.
Characterising an insulin-like growth factor (IGF) signature for early detection/risk reduction of cancer
30 November 2018
Researchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer.